Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections

Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections

November 24, 2008

PS-targeting antibodies may represent a new class of drugs with broad potential to treat viral infections

Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models.




Bavituximab is in clinical trials for the treatment of hepatitis C virus (HCV) infection and in preclinical development for the treatment of viral hemorrhagic fevers under a contract worth up to $44.4 million with the bioterrorism program of the U.S. Defense Threat Reduction Agency (DTRA). Bavituximab and other anti-PS antibodies are also being studied preclinically in HIV, cytomegalovirus (CMV) and other serious viral infections.

"Based on these findings, anti-PS antibodies such as bavituximab may represent a completely new class of drugs for the treatment of life-threatening viral infections," said study co-author Dr. Philip Thorpe, professor of pharmacology at UT Southwestern Medical Center and a scientific advisor to Peregrine. "By targeting a property of the host cell rather than the virus itself, anti-PS antibodies have the potential to treat a range of viral infections, and they should be less susceptible to the viral mutations that contribute to the development of drug resistance."

In the research reported today, scientists at UT Southwestern assessed the activity of bavituximab in animal models of two lethal viruses--cytomegalovirus and Lassa fever virus, a hemorrhagic fever virus that is listed as a class A bioterrorism agent by the CDC. Bavituximab showed potent anti-viral activity in both models.

Dr. Melina Soares, lead study author and UT Southwestern instructor of pharmacology, commented, "Recent non-affiliated research has further confirmed that exposed PS has immunosuppressive properties and is also clarifying its involvement during viral infection of cells. Our data go a step further, providing compelling evidence that exposed PS itself is a promising anti-viral drug target that is involved in the pathogenesis of multiple viruses, suggesting the possibility of achieving broad-spectrum anti-viral effects using a single anti-PS agent. We look forward to further exploring the potential of bavituximab and other anti-PS antibodies against viruses for which there are few or no effective therapeutic options."

In the first study, 100% of mice infected with lethal murine CMV and treated with bavituximab recovered fully, while only 25% of control animals survived. In the second study, guinea pigs were infected with lethal Pichinde virus, which is a model virus for Lassa fever. Fifty percent of the bavituximab-treated group survived, while untreated animals all died. In this study, the anti-viral effect of bavituximab was further augmented by the addition of the standard of care drug ribavirin, with 63% of animals receiving the combination therapy surviving the potentially lethal infection.

"We are extremely pleased to see this research demonstrating the broad anti-viral potential of bavituximab and our anti-PS technology platform published in this highly regarded journal," said Steven W. King, president and CEO of Peregrine. "This new publication is the latest in a series of external validations of our anti-viral program. It follows a recently awarded federal government contract for assessment of anti-PS antibodies to treat viral hemorrhagic fevers, research on the role of PS in viral infections that was published in a leading science journal earlier this year, and a recent presentation on anti-PS antibodies at a global HIV conference."

Mr. King added, "Better prevention and treatment of viral diseases are urgently needed, and we are increasingly optimistic that bavituximab and our other anti-PS antibodies could be valuable contributors to the field."

PS is a lipid molecule normally found on the inside of cell membranes that "flips" and becomes exposed on the outside of the membranes of enveloped viruses and virally infected cells. Exposed PS enables viruses to evade immune recognition and dampens the body's normal responses to infection. By masking the exposed PS, bavituximab and other anti-PS antibodies may block these effects and allow the body to develop a robust immune response to the viral pathogen. Anti-PS antibodies have been shown to help clear infectious virus from the bloodstream and to induce antibody-dependent cellular cytotoxicity, an important anti-viral immune response.

Researchers have found that PS is exposed on the outer membrane of cells infected with HIV, influenza (including avian flu), herpes simplex viruses, hemorrhagic fever viruses, measles and members of the small pox and rabies virus families.

Dr. Barton Haynes, director of Duke University's Human Vaccine Institute and the Center for HIV/AIDS Vaccine Immunology (CHAVI) is currently investigating PS as a potential target for preventing HIV infection. He commented, "Targeting a host cell lipid such as PS as an anti-viral strategy is an intriguing concept that may have relevance for new therapeutic and possibly prophylactic innovations in a number of virus infections."

BioCom Partners



Related Viral Infection Current Events and Viral Infection News Articles Viral Infection Current Events and Viral Infection News RSS Viral Infection Current Events and Viral Infection News RSS
Newly Discovered Fat Molecule: An Undersea Killer with an Upside
A chemical culprit responsible for the rapid, mysterious death of phytoplankton in the North Atlantic Ocean has been found by collaborating scientists at Rutgers University and the Woods Hole Oceanographic Institution (WHOI). This same chemical may hold unexpected promise in cancer research.

New methods found useful for diagnosing myocarditis
Myocarditis is an important, and often unrecognized cause of dilated cardiomyopathy (DCM). Several new diagnostic methods, such as cardiac magnetic resonance imaging (MRI), are useful for diagnosing myocarditis, according to a study published in the November 2009 issue of Mayo Clinic Proceedings.

Immune therapy can protect against or treat later lymphoma
Specially developed immune system cells that target the common Epstein-Barr virus can protect immune-suppressed bone marrow transplant recipients against lymph system disease and cancers that arise from the viral infection.

Hepatitis B does not increase risk for pancreatic cancer
A Henry Ford Hospital study found that hepatitis B does not increase the risk for pancreatic cancer - and that only age is a contributing factor.

Modified crops reveal hidden cost of resistance
Genetically modified squash plants that are resistant to a debilitating viral disease become more vulnerable to a fatal bacterial infection, according to biologists.

Important new novel 2009 H1N1 flu advisory for cardiopulmonary transplantation
Each year 3-5 million people have severe cases and 250-500,000 die from complications of seasonal influenza world-wide. This year, the novel 2009 H1N1 (nH1N1) influenza, previously called swine flu, has reached pandemic status.

Earlier flu viruses provided some immunity to current H1N1 influenza, study shows
University of California, Davis, researchers studying the 2009 H1N1 influenza virus, formerly referred to as "swine flu," have identified a group of immunologically important sites on the virus that are also present in seasonal flu viruses that have been circulating for years.

LSUHSC researcher identifies new target to prevent fatal flu lung complication
Research led by Dr. Jay Kolls, Professor and Chairman of Genetics at LSU Health Sciences Center New Orleans, has identified a therapeutic target for acute lung injury resulting in acute respiratory distress syndrome, a highly fatal complication of influenza infection.

Pitt researchers net $5 million from NIH to explore better ways to grow cells for regenerative medicine
Regenerative medicine researchers at the University of Pittsburgh received two grants totaling more than $5 million from the National Institutes of Health (NIH) to explore new methods for cultivating replacement cells from existing tissues and organs.

Genetic hint for ridding the body of hepatitis C
More than seventy percent of people who contract Hepatitis C will live with the virus that causes it for the rest of their lives and some will develop serious liver disease including cancer.
More Viral Infection Current Events and Viral Infection News Articles
Laboratory Diagnosis of Viral Infections, Third Edition

Laboratory Diagnosis of Viral Infections, Third Edition
by Thomas Smith (Editor)

Maintaining the features that made the previous editions so successful, the Third Edition of Laboratory Diagnosis of Viral Infections summarizes the clinical, epidemiological, pathogenetic, and immunological features of a certain disease or infection-providing laboratorians with a practical tool for the principles and techniques used in diagnostic virology.
Contains a new chapter covering the important Hantavirus Pulmonary Syndrome!
Fully updated since the last edition was published eight years ago and alphabetically arranged for quick and easy reference, Laboratory Diagnosis of Viral Infections, Third Edition now contains:
a complete update on human herpesviruses 6, 7, and 8
expanded coverage of hepatitis, including enterically transmitted hepatitis viruses and...

Viral Infection

Viral Infection
Gash (Primary Contributor)



PetAlive Vi-Pro Plus for Canine Distemper and Viral Infections (20g)

PetAlive Vi-Pro Plus for Canine Distemper and Viral Infections (20g)
by PetAlive

PetAlive Vi-Pro Plus combines a Distemperinum nosode in homeopathic dose with homeopathic Bryonia and an herbal preparation of Echinacea, providing powerful protection against Distemper as well as many other viral illnesses. Used preventatively to immunize your dog, or curatively under the treatment of a homeopathic vet, Vi-Pro Plus can mean the difference between life and death. Use Vi-Pro Plus as an oral homeopathic vaccine to immunize your dog against Canine Distemper and other viral infections; to protect against Distemper infection during a known outbreak and to treat active Canine Distemper under veterinarian supervision.

LWW Understanding Viral Infections Anatomical Chart Laminated (In Stock Special)-9775PL1.5

LWW Understanding Viral Infections Anatomical Chart Laminated (In Stock Special)-9775PL1.5
by Anatomical Chart Company

LWW Understanding Viral Infections Anatomical Chart Laminated is a part of the Anatomical Chart Company's Cellular Chart Series, this college and physician-level chart uses images and text to explain the general structure of a virus and how a virus infects cells. The chart also explains how viruses are transmitted and how they enter and spread in the body. Other charts in this series include The Development of Blood Cells, Understanding Bacterial Infections, and Understanding Human DNA.

Warts, Herpes Simplex, and Other Viral Infections  Chapter 12: Clinical Dermatology, 4th Edition

Warts, Herpes Simplex, and Other Viral Infections Chapter 12: Clinical Dermatology, 4th Edition
by Thomas P. Habif (Author)

The 4th Edition of this popular reference presents a wealth of new features to enable readers to identify, treat, and manage skin diseases. Atlas-like guidance, complemented with detailed, diagnostic text, combine to offer readers a user-friendly resource. This book is widely recognized as the world's leading dermatologic manual. Chapter 12, from this highly recommended reference book, offers 41 pages of current and comprehensive information about Warts, Herpes Simplex, and Other Viral Infections.

ABC News 20/20 Cleaning Up the Germ Myths

ABC News 20/20 Cleaning Up the Germ Myths

Does antibacterial soap keep your family healthier than regular soap? Is the air on an airplane as bad for you as the pillow on the flight? From public bathrooms to your kitchen at home, from airplanes to the office, from hospitals to makeup counters, "20/20" correspondents talk to experts who give the facts -- and some useful tips -- about germs.

This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.

CELL POWER 1 fl oz.

CELL POWER 1 fl oz.
by Positive POWER Nutrition

Cellular Oxygenation and Detoxification may be useful for people who suffer from the following conditions: Allergies pH imbalances Emphysema Indigestion Chronic obstructive pulmonary disease (COPD) Kidney infections Chronic fatigue syndrome Skin disorders Bronchial asthma Arthritis and joint pain Short-term memory loss Fibromyalgia Viral, fungal, and bacterial infections Muscle pain 1. A man in Pennsylvania suffering with Leukemia (blood cancer) 4 years, told that all of his options had run out, sent home to die. I personally spoke with this man, named Charles (Chuck). He stated that he was sent home to die in Dec 2006. He didn't feel his time on earth was up, so he started taking several good dietary supplements, including CellPowerTM, and then...

Melissa Oil 100% 1mL (organic/biodynamic)

Melissa Oil 100% 1mL (organic/biodynamic)
by Primavera

Gentle, warm Melissa Oil has a touch of honey. It is balancing, strengthening, protective, stimulating and for emotional problems. Use it in the diffuser, in compresses, relaxing baths, for lip care, for delicate facial oils. Often used for nervousness, tension, stress, insomnia, infections, fungal infections, viral infections, herpes virus, cold sores and eczema.

Viral Infections of the Nervous System (Books)

Viral Infections of the Nervous System (Books)
by Richard T. Johnson (Author)

Johns Hopkins Univ., Baltimore, MD. Emphasizes the biology of nervous-system infections based on the premise that only an understanding of mechanisms can lead to rational and innovative diagnosis and therapy. Previous edition: c1982. DNLM: Virus Diseases.

PetAlive Vi-Pro Plus for Canine Distemper and Viral Infections

PetAlive Vi-Pro Plus for Canine Distemper and Viral Infections
by PetAlive

Canine distemper is a highly contagious, extremely serious viral disease which occurs in dogs and other wild canids (e.g.. foxes, wolves and coyotes), raccoons, skunks and ferrets. It is an airborne virus, which affects the respiratory, gastrointestinal, and central nervous system of the animal. Puppies between three and six months and elderly animals are particularly at risk. Symptoms grow increasingly severe as the disease progresses and they include Conjunctivitis (a watery, pus-like eye discharge) and inflammation of the eye; Fever; Nasal discharge; Pneumonia (Coughing and labored breathing); Lethargy; Reduced appetite; Vomiting; Diarrhea; Seizures; Hyperesthesia (increased sensitivity to sensory stimuli, such as pain or touch); Muscle twitching; Progressive deterioration of mental...

© 2009 BrightSurf.com